Published ahead of print on April 29, 2004, doi:10.1164/rccm.200304-578OC
Am. J. Respir. Crit. Care Med., Volume 170, Number 4, August 2004, 395-399
A more recent version of this article appeared on August 15, 2004
Submitted on April 27, 2003
Accepted on April 23, 2004
Angiotensin Converting Enzyme Genotype and Strength in Chronic Obstructive Pulmonary Disease
Nicholas S Hopkinson1*, Annabel H Nickol1, John Payne2, Emma Hawe2, William D-C Man3, John Moxham3, Hugh Montgomery2, and Michael I Polkey1
1 Respiratory Muscle Laboratory, Royal Brompton Hospital, London, United Kingdom,
2 Department of Cardiovascular Genetics, Rayne Institute, London, United Kingdom,
3 Respiratory Muscle Laboratory, King's College Hospital, Guy's King's and St. Thomas' School of Medicine, London, United Kingdom
* To whom correspondence should be addressed. E-mail: n.hopkinson{at}ic.ac.uk.
Quadriceps muscle weakness is an important contributor to exercise limitation in patients with chronic obstructive pulmonary disease. The deletion allele of the angiotensin converting enzyme gene polymorphism has previously been associated with a greater response to strength training in healthy subjects and might therefore protect against detraining in these patients. In 103 stable outpatients (mean FEV1 34.4(16.5)% predicted) the deletion allele was associated with greater isometric quadriceps strength; mean(SD) 31.4(10.8) Kg for insertion homozygotes, 34.1(13.0) Kg for heterozygotes and 38.3(11.6) Kg for deletion homozygotes (p=0.04 linear trend). Adjusted for fat free mass the relationship was stronger (linear trend p=0.007). There was no relationship between strength and genotype in a group of 101 age-matched healthy controls. Twitch quadriceps force in response to magnetic femoral nerve stimulation, measured in 39 patients was also genotype dependent; 8.3(2.6) Kg for insertion homozygotes, 10.1(3.6) Kg for heterozygotes and 12.4(3.5) Kg for deletion homozygotes (p=0.002 linear trend). Body mass index and fat free mass did not differ significantly between genotypes in either group. There was no association in either patients or controls between genotype and inspiratory muscle strength. In chronic obstructive pulmonary disease the deletion allele is associated with greater quadriceps strength independent of confounding factors.
Key words: Gene polymorphism, skeletal muscle, respiratory muscle
This article has been cited by other articles:

|
 |

|
 |
 
T. McCauley, S. S. Mastana, J. Hossack, M. MacDonald, and J. P. Folland
Human angiotensin-converting enzyme I/D and {alpha}-actinin 3 R577X genotypes and muscle functional and contractile properties
Exp Physiol,
January 1, 2009;
94(1):
81 - 89.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Future Treatments for Chronic Obstructive Pulmonary Disease and Its Comorbidities
Proceedings of the ATS,
December 1, 2008;
5(8):
857 - 864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Wagner
Possible mechanisms underlying the development of cachexia in COPD
Eur. Respir. J.,
March 1, 2008;
31(3):
492 - 501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S Hopkinson, K. W. Li, A. Kehoe, S. E Humphries, M. Roughton, J. Moxham, H. Montgomery, and M. I Polkey
Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease
Am. J. Clinical Nutrition,
February 1, 2008;
87(2):
385 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Barreiro, A M W J Schols, M I Polkey, J B Galdiz, H R Gosker, E B Swallow, C Coronell, J Gea, and on behalf of the ENIGMA in COPD project
Cytokine profile in quadriceps muscles of patients with severe COPD
Thorax,
February 1, 2008;
63(2):
100 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B Swallow, D. Reyes, N. S Hopkinson, W. D-C Man, R. Porcher, E. J Cetti, A. J Moore, J. Moxham, and M. I Polkey
Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease
Thorax,
February 1, 2007;
62(2):
115 - 120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Meysman
Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial.
Eur. Respir. J.,
September 1, 2006;
28(3):
670 - 670.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Andreas
From the authors
Eur. Respir. J.,
September 1, 2006;
28(3):
670 - 671.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Andreas, C. Herrmann-Lingen, T. Raupach, L. Luthje, J. A. Fabricius, N. Hruska, W. Korber, B. Buchner, C-P. Criee, G. Hasenfuss, et al.
Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial
Eur. Respir. J.,
May 1, 2006;
27(5):
972 - 979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S Hopkinson, K. I Eleftheriou, J. Payne, A. H Nickol, E. Hawe, J. Moxham, H. Montgomery, and M. I Polkey
+9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease.
Am. J. Clinical Nutrition,
April 1, 2006;
83(4):
912 - 917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Spruit, R. Gosselink, T. Troosters, A. Kasran, M. Van Vliet, and M. Decramer
Low-Grade Systemic Inflammation and the Response to Exercise Training in Patients With Advanced COPD
Chest,
November 1, 2005;
128(5):
3183 - 3190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Van Vliet, M. A. Spruit, G. Verleden, A. Kasran, E. Van Herck, F. Pitta, R. Bouillon, and M. Decramer
Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
November 1, 2005;
172(9):
1105 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W D-C Man, N S Hopkinson, F Harraf, D Nikoletou, M I Polkey, and J Moxham
Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease
Thorax,
September 1, 2005;
60(9):
718 - 722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
July 1, 2005;
172(1):
19 - 38.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med.,
April 1, 2005;
171(7):
686 - 698.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Gosker, H.-J. Pennings, and A. M. W. J. Schols
ACE Gene Polymorphism in COPD
Am. J. Respir. Crit. Care Med.,
September 1, 2004;
170(5):
572 - 572.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Hopkinson, A. H. Nickol, J. Payne, E. Hawe, W. D.-C. Man, J. Moxham, H. Montgomery, and M. I. Polkey
ACE Gene Polymorphism in COPD
Am. J. Respir. Crit. Care Med.,
September 1, 2004;
170(5):
572 - 573.
[Full Text]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|